Diabetes Relief LLC is pleased to announce that Brian Loveridge, M.D., has been named its new Chief Medical Officer for the entire operation. Dr. Loveridge replaces Stanley T. Lewis, Jr., M.D., who has served Diabetes Relief so well since 2016 in developing its patented and patent-pending treatment for metabolic disorder. Dr. Lewis is named Senior Medical Advisor and will continue to serve on the company’s Medical Advisory Board as he is becoming more involved in international pursuits with his other medical and business interests. Dr. Loveridge will continue to serve as Medical Director for the Utah facility, and he will continue his very important work with Diabetes Relief’s training and educational sessions for licensees.
Recent Posts
Categories
Archives
- November 2024
- October 2020
- September 2020
- August 2020
- June 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
